Samrat Pharmachem Ltd

₹ 675 -2.28%
27 Jan - close price
About

Samrat Pharmachem Ltd is primarily engaged in manufacturing of various types of Iodine compounds.[1]

Key Points

Product Offerings
The company's product offerings include various types of iodine compounds[1] which find applications in Pharmaceutical, FMCG, Animal Feed, Chemicals and Agrochemical industries.[2]

  • Market Cap 209 Cr.
  • Current Price 675
  • High / Low 1,250 / 366
  • Stock P/E 7.26
  • Book Value 201
  • Dividend Yield 0.15 %
  • ROCE 52.4 %
  • ROE 45.0 %
  • Face Value 10.0

Pros

  • Company is expected to give good quarter
  • Company has delivered good profit growth of 58.1% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 30.6%

Cons

  • Promoter holding has decreased over last quarter: -0.90%
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
36.54 35.20 30.28 35.27 41.50 54.85 47.41 47.24 59.08 55.34 60.16 86.51 71.12
34.47 34.32 29.35 33.65 38.84 52.40 45.46 45.82 54.92 46.73 50.00 73.63 62.86
Operating Profit 2.07 0.88 0.93 1.62 2.66 2.45 1.95 1.42 4.16 8.61 10.16 12.88 8.26
OPM % 5.67% 2.50% 3.07% 4.59% 6.41% 4.47% 4.11% 3.01% 7.04% 15.56% 16.89% 14.89% 11.61%
0.42 0.00 0.07 0.02 0.02 0.09 0.30 0.15 0.07 0.23 0.07 0.03 0.16
Interest 0.23 0.25 0.33 0.46 0.28 0.36 0.17 0.17 0.21 0.13 0.17 0.23 0.24
Depreciation 0.11 0.11 0.11 0.11 0.12 0.13 0.13 0.14 0.15 0.15 0.15 0.16 0.16
Profit before tax 2.15 0.52 0.56 1.07 2.28 2.05 1.95 1.26 3.87 8.56 9.91 12.52 8.02
Tax % 30.23% 9.62% 30.36% 25.23% 37.28% 25.37% 19.49% 24.60% 27.91% 24.77% 29.47% 25.24% 26.31%
Net Profit 1.50 0.47 0.39 0.80 1.44 1.54 1.56 0.95 2.79 6.45 6.99 9.37 5.91
EPS in Rs 4.85 1.52 1.26 2.59 4.66 4.98 5.05 3.07 9.03 20.88 22.62 30.33 19.13
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
43 70 72 65 47 63 73 93 111 137 179 222 273
41 63 71 64 46 62 69 87 108 131 170 197 233
Operating Profit 2 6 1 1 1 1 4 6 3 7 9 24 40
OPM % 6% 9% 2% 1% 2% 2% 5% 6% 3% 5% 5% 11% 15%
0 0 1 1 0 0 0 0 0 1 0 1 0
Interest 0 1 1 1 1 1 1 1 1 1 1 1 1
Depreciation 0 0 0 0 0 0 0 0 0 0 0 1 1
Profit before tax 2 6 1 0 0 0 3 5 2 6 7 24 39
Tax % 36% 35% 31% 41% 35% 33% 37% 35% 29% 27% 27% 27%
Net Profit 1 4 0 0 0 0 2 3 2 4 5 17 29
EPS in Rs 4.34 12.23 1.29 0.78 1.04 0.97 5.66 10.42 4.98 13.72 17.25 55.60 92.96
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 2%
Compounded Sales Growth
10 Years: 12%
5 Years: 25%
3 Years: 26%
TTM: 31%
Compounded Profit Growth
10 Years: 16%
5 Years: 58%
3 Years: 123%
TTM: 320%
Stock Price CAGR
10 Years: 36%
5 Years: 45%
3 Years: 91%
1 Year: 58%
Return on Equity
10 Years: 18%
5 Years: 26%
3 Years: 31%
Last Year: 45%

Balance Sheet

Figures in Rs. Crores

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
3 3 3 3 3 3 3 3 3 3 3 3 3
Reserves 6 9 10 10 10 11 12 15 17 21 27 44 59
2 3 4 3 3 6 7 9 7 9 9 8 29
8 16 17 15 10 17 14 13 14 25 19 30 20
Total Liabilities 19 32 34 31 26 36 36 41 40 58 57 85 111
3 4 4 8 7 7 7 7 7 7 9 10 10
CWIP 0 3 4 0 0 0 0 0 0 1 0 0 0
Investments 0 0 0 0 0 2 0 0 0 0 0 0 2
16 25 27 24 19 27 29 34 33 50 48 75 99
Total Assets 19 32 34 31 26 36 36 41 40 58 57 85 111

Cash Flows

Figures in Rs. Crores

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
-1 4 -2 4 -1 -0 -3 0 2 -1 5 18
-1 -4 -1 -0 0 -2 1 -2 2 -2 -3 -1
0 2 1 -1 0 2 1 2 -4 2 -2 -2
Net Cash Flow -2 2 -2 2 -0 -0 -1 -1 1 -1 -0 14

Ratios

Figures in Rs. Crores

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 79 55 60 63 74 93 59 86 69 74 67 72
Inventory Days 30 46 54 45 38 37 41 31 28 55 25 24
Days Payable 78 86 89 87 76 104 43 46 45 67 39 45
Cash Conversion Cycle 31 15 25 21 36 26 58 70 52 61 53 51
Working Capital Days 50 27 37 25 39 35 61 65 56 63 54 44
ROCE % 25% 49% 9% 7% 7% 5% 16% 23% 12% 22% 24% 52%

Shareholding Pattern

Numbers in percentages

Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
49.13 49.13 49.13 49.13 49.30 49.30 49.30 49.65 49.65 49.65 49.54 48.64
0.00 3.24 0.00 3.24 3.24 3.24 3.24 0.00 0.00 3.24 3.24 3.24
3.24 0.00 3.24 0.00 0.00 0.00 0.00 3.24 3.24 0.00 0.00 0.00
47.63 47.63 47.63 47.63 47.46 47.46 47.46 47.12 47.12 47.12 47.23 48.13

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents